Start free trial

Latest Eikon Therapeutics News & Updates

See the latest news and media coverage for Eikon. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Eikon Therapeutics (Eikon)

Late-stage clinical biopharmaceutical company

eikontx.com
Headquarters
Millbrae, United States
Founded year
2019
Company type
Private company
Number of employees
430–500
Industry
Pharmaceuticals

Last updated

Latest news about Eikon Therapeutics (Eikon)

In short: Eikon presented updated EIK1001 NSCLC data at ESMO, with a 72% response rate in the squamous cohort.

Company announcements

Eikon

Eikon files Q2 2026 SEC 10-Q after IPO

The filing reports net losses of $171.4 million for the first half of 2026 and cash holdings of $531.2 million following a February initial public offering.

Eikon

Eikon Therapeutics appoints Ma. Fatima D. Francisco to its Board of Directors

The biotech company named Francisco a Class I director on June 15, 2026, granting her an initial stock option award valued at the current share price.

Unlock all announcements with a

Media coverage

Yahoo Finance

Eikon Therapeutics Eyes Safer PARP1 Cancer Treatments With EIK1003, EIK1004

Eikon Therapeutics (NASDAQ:EIKN) outlined its development strategy for selective PARP1 inhibitors and its Werner helicase ...

Unlock all articles with a

Never miss news about Eikon

Track Eikon and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Eikon competitors & trending companies

Browse news for competitors to Eikon and other trending companies.